After 5 Years Cervical Cancer Vaccine Tested in Brazil and US Keeps Working

Young woman gets a cervical cancer vaccine shot As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress. While HPV vaccine efforts had the "benefit" of a viral source for the disease, other researchers are developing vaccines for cancers that are not virally based, in an effort to coax the immune system into attacking cancerous cells.

Today at the 2007 Annual Meeting of the American Association for Cancer Research, presentations on ongoing HPV trials and other new approaches to stimulating the immune system are injecting momentum into cancer vaccine research.

Ongoing evaluation of a phase II trial of a human papillomavirus vaccine, developed to prevent cervical cancer, shows that the vaccine continues to protect against HPV types 16 and 18 at five and a half years into the study, according to researchers from the University of Louisville. Their findings also show that the vaccine offers significant cross-protection for HPV types 45 and 31.

The study follows 1113 women between the ages of 15 and 25 in North America and Brazil randomized to receive three doses of either the vaccine or the control. The vaccine, made by GlaxoSmithKline, which funded the study, is designed to protect against two strains of HPV, types 16 and 18, which together are thought to cause nearly 72 percent of all cases of cervical cancer.

At over five years into the study’s follow-up, the researchers found that approximately 98 percent of subjects still maintained protection against HPV types 16 and 18. Regardless of HPV status, the vaccine also appears to prevent most occurrences of cervical intraepithelial neoplasia lesions – abnormal, precancerous cell growths found in the cervix.

They also found that the vaccination offered significant protection against genetically similar viruses. They determined the vaccine to be 88 percent effective against HPV type 45 and 54 percent effective against HPV type 31.

"Overall, it is not a surprise that the vaccine offers protection against additional types of human papillomavirus, as they are all related genetically," said Stanley Gall, M.D., professor at the University of Louisville. "However, as you get genetically farther from types 16 and 18, you would expect to see less cross-protection."

According to Dr. Gall, effective preventative treatment with the vaccine will depend on the long-term and broad protection the vaccine can offer against cancer-causing HPV types.

Tags:

Ads

You May Also Like

Central Bank Forecasts Brazil’s GDP Will Grow 5.8% in 2010

Brazil's Gross Domestic Product (GDP) will grow 5.8% in the coming year. The projection ...

Brazil’s Bank to Finance Mercosur’s Auto Sector

Brazil’s Minister of Development, Industry and Foreign Trade, Luiz Fernando Furlan, says that the ...

Bar Association Wants 10 Brasília’s Assemblymen Ousted

This past December 16, the Federal District Legislative Assembly, which like other legislative bodies ...

Brazil Is Mad: ‘We Pay the Bills. Why the High Premium Abroad?’

The Brazilian Minister of Development, Industry, and Foreign Trade, Luiz Fernando Furlan, said that ...

Brazil’s Industry Output Grows Meager 0.1% After 4 Months of Decline

Brazilian industrial output rose 0.1% in October, interrupting four consecutive months of decreases, reports ...

Lula Visits a Piece of Brazil in Antarctica and Gets Emotional

Brazil's President, Luiz Inácio Lula da Silva confessed that he felt overwhelmed during his ...

Brazilian Media Continues Assault with Damming Stories on Hard-to-Fall Labor Minister

Carlos Lupi, Brazil’s minister of Labor is once again under a barrage of accusations ...

But We Survived

By late evening firecrackers were popping continuously and the smoke in the street was ...

Brazilian Ballet Shoe Maker Dancing on Foreign Floors

Capezio, a traditional Brazilian maker of ballet shoes, shoes, gym and dance clothes and ...

Brazil Getting Less Kick out of Soccer

While soccer in North America can boast of some successful signs of positive growth, ...